Charles River Laboratories International (CRL) Accounts Payables (2016 - 2025)
Charles River Laboratories International has reported Accounts Payables over the past 17 years, most recently at $148.8 million for Q4 2025.
- Quarterly results put Accounts Payables at $148.8 million for Q4 2025, up 6.03% from a year ago — trailing twelve months through Dec 2025 was $148.8 million (up 6.03% YoY), and the annual figure for FY2025 was $148.8 million, up 6.03%.
- Accounts Payables for Q4 2025 was $148.8 million at Charles River Laboratories International, down from $169.6 million in the prior quarter.
- Over the last five years, Accounts Payables for CRL hit a ceiling of $226.0 million in Q1 2022 and a floor of $110.9 million in Q2 2021.
- Median Accounts Payables over the past 5 years was $143.1 million (2024), compared with a mean of $155.4 million.
- Biggest five-year swings in Accounts Payables: soared 90.56% in 2022 and later tumbled 46.9% in 2023.
- Charles River Laboratories International's Accounts Payables stood at $198.1 million in 2021, then increased by 3.93% to $205.9 million in 2022, then decreased by 17.96% to $168.9 million in 2023, then decreased by 16.93% to $140.3 million in 2024, then grew by 6.03% to $148.8 million in 2025.
- The last three reported values for Accounts Payables were $148.8 million (Q4 2025), $169.6 million (Q3 2025), and $145.8 million (Q2 2025) per Business Quant data.